Institutional News

Last Days to Sign Up to SOLACI-SOCIME 2022 with 15% OFF

solaci
solaci
414
0

SOLACI-SOCIME 2022

LAST DAYS TO SIGN UP WITH 15% OFF

We are a little less than one month away from the most relevant meeting of interventional cardiology in Latin America.

This year we celebrate the long-awaited return to our face to face meetings. This is why we have prepared an innovative scientific program with challenging live and edited cases, prestigious international guests, outstanding symposia with the most relevant topics in the field, interesting academic debates and much more.

Do not miss this unique opportunity to make part of this event with 15% discount.

Register Now with 15% Discount

Discover the Preliminary Program

MORE INFORMATION ON THE CONGRESS

Call For Science – Last Days
Send your work before July 15 and introduce yourself to your colleagues around the world as an expert.
Send Your Work Now 

 

Live Cases
We will be broadcasting challenging live cases from 4 specialized centers in México and from Argentina.
Read Moreae

 

Sponsored Scientific Activities
Find out about innovative sessions in interventional cardiology sponsored by the industry.
Read More

 

Highlights | Why attend?
Find out why you cannot miss this event in the following link.
Read More 

 

Lodging Options
Book your stay in Mexico during SOLACI-SOCIME 2022 at the best hotels in the city at a special rate.
Read More

 

Register Now with 15% off

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
Same Day Discharge in NSTE-ACS: Is It Possible?
Next article
Watch again Disruptive and Conventional Treatments Below The Knee and in the Superficial Femoral Artery – SOLACI Webinar
solaci
solaci

More articles by this author

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

solaci - 0
Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

solaci - 0
The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

solaci - 0
Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

solaci - 0
The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Institutional News

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology...
solaci -
SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

Dr. Omar Tupayachi - 0
The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Dr. Omar Tupayachi - 0
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Dr. Omar Tupayachi - 0
Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...